Related Experiment Video
Updated: Feb 19, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
Published on: September 9, 2020
TRIM proteins in blood cancers
Lisa J Crawford1, Cliona K Johnston1, Alexandra E Irvine2
1Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Abstract:
Post-translational modification of proteins with ubiquitin plays a central role in regulating numerous cellular processes. E3 ligases determine the specificity of ubiquitination by mediating the transfer of ubiquitin to substrate proteins. The family of tripartite motif (TRIM) proteins make up one of the largest subfamilies of E3 ligases. Accumulating evidence suggests that dysregulation of TRIM proteins is associated with a variety of diseases. In this review we focus on the involvement of TRIM proteins in blood cancers.
Insights
Tripartite motif (TRIM) proteins are crucial E3 ligases regulating cellular functions. This review highlights their significant involvement in the development and progression of various blood cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Post-translational modification via ubiquitination is vital for cellular processes.
- E3 ligases, including the tripartite motif (TRIM) family, dictate ubiquitination specificity.
- Dysregulation of TRIM proteins is linked to diverse pathologies.
Purpose of the Study:
- To review the role of tripartite motif (TRIM) proteins in hematological malignancies.
- To consolidate current understanding of TRIM protein involvement in blood cancers.
Main Methods:
- Literature review of scientific articles and research papers.
- Focus on studies investigating TRIM proteins and their association with blood cancers.
Main Results:
- TRIM proteins are a large subfamily of E3 ligases with critical cellular functions.
- Evidence links TRIM protein dysregulation to various diseases, particularly blood cancers.
Conclusions:
- TRIM proteins represent a significant area of research in hematologic oncology.
- Further investigation into TRIM proteins may reveal novel therapeutic targets for blood cancers.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

